Joji Suzuki

2.8k total citations · 1 hit paper
96 papers, 1.8k citations indexed

About

Joji Suzuki is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Pharmacology. According to data from OpenAlex, Joji Suzuki has authored 96 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Public Health, Environmental and Occupational Health, 30 papers in Epidemiology and 19 papers in Pharmacology. Recurrent topics in Joji Suzuki's work include Opioid Use Disorder Treatment (46 papers), Pain Management and Opioid Use (18 papers) and Substance Abuse Treatment and Outcomes (17 papers). Joji Suzuki is often cited by papers focused on Opioid Use Disorder Treatment (46 papers), Pain Management and Opioid Use (18 papers) and Substance Abuse Treatment and Outcomes (17 papers). Joji Suzuki collaborates with scholars based in United States, Japan and Canada. Joji Suzuki's co-authors include Christin N. Price, Bessel A. van der Kolk, Mary W. Montgomery, Jennifer A. Burbridge, Jennifer A. Johnson, Florina Haimovici, Grace Chang, Justin L. Poklis, Alphonse Poklis and Saeed Ahmed and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Joji Suzuki

82 papers receiving 1.7k citations

Hit Papers

A review: Fentanyl and non-pharmaceutical fentanyls 2016 2026 2019 2022 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A review: Fentanyl and non-pharmaceutical fentanyls
    2016 319 citations Joji Suzuki et al. profile →

Peers

Joji Suzuki
Karl A. Sporer United States
Kim Wolff United Kingdom
Amanda Roxburgh Australia
Emily B. Einstein United States
Jermaine D. Jones United States
Bruna Brands Canada
Michael F. Weaver United States
Bridin Murnion Australia
Paul A. Nuzzo United States
Gary M. Reisfield United States
Karl A. Sporer United States
Joji Suzuki
Citations per year, relative to Joji Suzuki Joji Suzuki (= 1×) peers Karl A. Sporer

Countries citing papers authored by Joji Suzuki

Since Specialization
Citations

This map shows the geographic impact of Joji Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joji Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joji Suzuki more than expected).

Fields of papers citing papers by Joji Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joji Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joji Suzuki. The network helps show where Joji Suzuki may publish in the future.

Co-authorship network of co-authors of Joji Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Joji Suzuki. A scholar is included among the top collaborators of Joji Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joji Suzuki. Joji Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Winder, Gerald Scott, Juan Pablo Arab, Gene Y. Im, et al.. (2025). From embedded interprofessional clinics to expanded alcohol-associated liver disease programs. Liver Transplantation. 31(12). 1567–1580. 1 indexed citations
2.
3.
Song, Wenyu, Kenneth J. Mukamal, Joji Suzuki, et al.. (2025). Trends and factors associated with opioid prescribing from 2017 to 2023. Pain. 167(1). 218–225.
4.
Suzuki, Joji, et al.. (2024). N-methyl-d-aspartate (NMDA) receptor antagonists for treatment of catatonia in adults: Narrative review. General Hospital Psychiatry. 91. 60–65.
5.
Paras, Molly L, et al.. (2024). Real-World Dalbavancin Use for Serious Gram-Positive Infections: Comparing Outcomes Between People Who Use and Do Not Use Drugs. Open Forum Infectious Diseases. 11(4). ofae186–ofae186. 9 indexed citations
6.
Sager, Zachary, et al.. (2024). Survey of Massachusetts peer recovery coaches’ attitudes toward the use of psychedelics to treat substance use disorders. Addiction Science & Clinical Practice. 19(1). 86–86.
7.
Wurcel, Alysse G., Joji Suzuki, Asher J Schranz, et al.. (2024). Strategies to Improve Patient-Centered Care for Drug Use-Associated Infective Endocarditis. Journal of the American College of Cardiology. 83(14). 1338–1347. 2 indexed citations
8.
9.
Hathaway, David, et al.. (2023). Patients' experiences with continuation or discontinuation of buprenorphine before painful procedures: A brief report. American Journal on Addictions. 32(4). 410–414. 2 indexed citations
10.
Winder, Gerald Scott, David Hathaway, Ponni Perumalswami, et al.. (2023). “But I didn’t drink!”: What to do with discordant phosphatidylethanol results. Liver Transplantation. 30(2). 213–222. 10 indexed citations
11.
Suzuki, Joji, Bianca Martin, David Smelson, et al.. (2023). A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial. Journal of Addiction Medicine. 17(5). 604–607. 3 indexed citations
12.
Suzuki, Joji, et al.. (2023). Case series: Voluntary discontinuation of sublingual buprenorphine treatment for opioid use disorder using extended‐release buprenorphine. American Journal on Addictions. 32(3). 314–317. 3 indexed citations
13.
Shay, Jessica E.S., Augustin Vannier, Stephanie Tsai, et al.. (2023). Moderate-high intensity exercise associates with reduced incident alcohol-associated liver disease in high-risk patients. Alcohol and Alcoholism. 58(5). 472–477. 3 indexed citations
14.
15.
Suzuki, Joji, et al.. (2022). Cannabidiol Effect on Cue-Induced Craving for Individuals with Opioid Use Disorder Treated with Buprenorphine: A Small Proof-of-Concept Open-Label Study. SHILAP Revista de lepidopterología. 1(1). 157–163. 10 indexed citations
16.
17.
Milliken, Aimee, et al.. (2020). The Opioid Crisis and the Inpatient Floor: Considering Injection Drug Use in the Management of Infective Endocarditis and Acute Pain. Harvard Review of Psychiatry. 28(5). 334–340. 3 indexed citations
18.
Suzuki, Joji, Jennifer A. Johnson, Mary W. Montgomery, et al.. (2019). Long-term Outcomes of Injection Drug-related Infective Endocarditis Among People Who Inject Drugs. Journal of Addiction Medicine. 14(4). 282–286. 23 indexed citations
19.
Suzuki, Joji, Jeffrey DeVido, D. Kalra, et al.. (2014). Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series. American Journal on Addictions. n/a–n/a. 3 indexed citations
20.
Matsuda, Juzo, et al.. (2000). Composting of food refuse from a student restaurant in Hokkaido University. Journal of Material Cycles and Waste Management. 2(2). 143–149. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karl A. Sporer Breakdown of academic impact, for papers by Kim Wolff Breakdown of academic impact, for papers by Amanda Roxburgh Breakdown of academic impact, for papers by Emily B. Einstein Breakdown of academic impact, for papers by Jermaine D. Jones Breakdown of academic impact, for papers by Bruna Brands Breakdown of academic impact, for papers by Michael F. Weaver Breakdown of academic impact, for papers by Bridin Murnion Breakdown of academic impact, for papers by Paul A. Nuzzo Breakdown of academic impact, for papers by Gary M. Reisfield
Rankless by CCL
2026